WebConclusion: Bevacizumab with cisplatin and paclitaxel for treating persistent, recurrent or metastatic cervical cancer is feasible and well tolerated. Loco-regional recurrence was most frequent. Overall survival was worse with recurrence at >2 sites or distant metastases. KW - Bevacizumab. KW - Cervical cancer. KW - Efficacy. KW - Recurrence ... WebStudies were critically appraised for risk of bias (QUIPS). For prognosis, the primary outcome was progression to muscle-invasive or metastatic disease. Secondary outcomes were disease recurrence, overall and cancer-specific survival. For reproducibility, the primary outcome was inter-observer variability between pathologists.
BRCA Mutation Association with Recurrence Score and …
WebRecurrence of primary disease is one of the major risks for allograft loss after pediatric RTx. The risk of recurrence of FSGS/SRNS after pediatric RTx in particular can be up to 86% in … WebThe traditional metric of ablation success, recurrence > 30 s at 1 year, is below the detection capabilities of almost all monitoring techniques yet still undervalues the efficacy of AF interventions. Measures of AF burden reduction and duration give a more complete assessment of the impact of AF surgeries and ablation. ... KW - ablation. KW ... checklist travel to canada
Clinical practice recommendations for recurrence of focal and …
WebIn particular, as a consequence, for an infinite half line, we show that localization of the QW can be ensured by the positive recurrence of the corresponding RWs, and also that the existence of only one self loop affects localization properties. KW - Localization. KW - Quantum Walk. KW - Random Walk. KW - Recurrence Property WebBackground: Preoperative prediction of bladder cancer (BCa) recurrence risk is critical for individualized clinical management of BCa patients. Purpose: To develop and validate a nomogram based on radiomics and clinical predictors for personalized prediction of the first 2 years (TFTY) recurrence risk. Study Type: Retrospective. WebIn summary, the underlying liver condition that led to end-stage liver disease and liver transplantation may recur after liver transplantation. The clinical expression of the recurrence of the hepatic disease is modulated by the immunosuppression program unless we have an effective immunoprophylaxis and antiviral agents such as in hepatitis B. checklist trouwdag